UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000056910
Receipt number R000065041
Scientific Title The effects of vision and attention during obstacle avoidance in individuals with stroke
Date of disclosure of the study information 2025/02/03
Last modified on 2026/02/04 11:08:29

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The effects of vision and attention during obstacle avoidance in individuals with stroke

Acronym

The effects of vision and attention during obstacle avoidance in individuals with stroke

Scientific Title

The effects of vision and attention during obstacle avoidance in individuals with stroke

Scientific Title:Acronym

The effects of vision and attention during obstacle avoidance in individuals with stroke

Region

Japan


Condition

Condition

individuals with stroke who had hemiplegia

Classification by specialty

Rehabilitation medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The purpose of this study is to clarify the influence of visual field and attention on the rotation of the body of individuals with stroke and to consider approaches to prevent falls.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Contact with obstacles, rotation angle, margin to obstacles

Key secondary outcomes

Mini-Mental State Examination test(MMSE), 10m walking test (10MWT),
Berg Balance Scale (BBS), Activities-specific balance confidence (ABC),
Predicted and actual values of Functional Reach Test(FRT) and Timed up and Go test(TUG)


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

90 years-old >

Gender

Male and Female

Key inclusion criteria

Participants had been walking for at least one month after a first-time stroke and that they were able to walk independently for more than 100 m with or without an assistive device.

Key exclusion criteria

None of the participants had any indications of the following symptoms: (a) neurological, orthopedic, or other disorders that could affect walking, (b) history of visual deficits, (c) visual field deficits and visual-spatial neglect, and (d) a score of less than 24 on the Mini-Mental State Examination (MMS

Target sample size

17


Research contact person

Name of lead principal investigator

1st name Daisuke
Middle name
Last name Muroi

Organization

Chiba Prefectural University of Health and Sciences

Division name

Department of Rehabilitation Sciences, Faculty of Health Care Sciences

Zip code

2600801

Address

645-1 Nitona-cho, Chiba Chuo-ku, Chiba, Japan.

TEL

0433052132

Email

mutyon88@hotmail.com


Public contact

Name of contact person

1st name Daisuke
Middle name
Last name Muroi

Organization

Chiba Prefectural University of Health Sciences

Division name

Department of Rehabilitation Sciences, Faculty of Health Care Sciences

Zip code

2600801

Address

645-1 Nitona-cho, Chiba Chuo-ku, Chiba, Japan.

TEL

0433052132

Homepage URL


Email

mutyon88@hotmail.com


Sponsor or person

Institute

Other

Institute

Department

Personal name

Daisuke Muroi


Funding Source

Organization

Japan Society for the Promotion of Science

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor

Kameda medical center

Name of secondary funder(s)



IRB Contact (For public release)

Organization

Kameda Medical Center

Address

929 Higashi-cho Kamogawa Chiba, Japan

Tel

0470922211

Email

clinical_research@kameda.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2025 Year 02 Month 03 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications


Number of participants that the trial has enrolled

17

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2017 Year 10 Month 12 Day

Date of IRB

2017 Year 10 Month 12 Day

Anticipated trial start date

2017 Year 10 Month 12 Day

Last follow-up date

2025 Year 06 Month 30 Day

Date of closure to data entry

2025 Year 07 Month 31 Day

Date trial data considered complete

2025 Year 07 Month 31 Day

Date analysis concluded

2025 Year 08 Month 31 Day


Other

Other related information

Participants were asked to pass through a opening created by two screens 4m ahead of them without colliding with it. The experiment was conducted under conditions in which participants used glasses that restricted their downward field of vision, under a subtraction condition, or under a control condition with no restrictions. A total of 18 trials were conducted, with three for the paretic and the non-paretic side entry.


Management information

Registered date

2025 Year 02 Month 03 Day

Last modified on

2026 Year 02 Month 04 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000065041